People In Brief
This article was originally published in The Gray Sheet
Executive Summary
Endologix names former Bard exec to CEO post: Maker of Powerlink endoluminal stent grafts for abdominal aortic aneurysms names John McDermott president and CEO, effective May 12. McDermott formerly served as president of C.R. Bard's peripheral vascular division and brings 20 years of experience in the vascular device industry. He replaces Endologix' Paul McCormick, who will remain a director of the Irvine, Calif.-based company. The appointment follows "an extensive nationwide search," noted Endologix Chairman Franklin Brown. "We are confident that John has the ideal professional background to take our company to the next level.
You may also be interested in...
People In Brief
The latest moves by movers and shakers in the medical device and diagnostics industries
People In Brief
AGA Medical CEO and IPO: Structural heart defect devices firm names a new CEO June 20 and on the same day files with the U.S. Securities and Exchange Commission for an initial public stock offering to raise up to $200 million. Chief Operating Officer John Barr is appointed president and CEO to replace Frank Gougeon, who co-founded the company with Kurt Amplatz in 1995. AGA says that Gougeon has decided to transition from day-to-day company oversight to an expanded role in long-term strategic planning. He will remain a member of the company's board and will chair a new corporate development committee
People In Brief
AGA Medical CEO and IPO: Structural heart defect devices firm names a new CEO June 20 and on the same day files with the U.S. Securities and Exchange Commission for an initial public stock offering to raise up to $200 million. Chief Operating Officer John Barr is appointed president and CEO to replace Frank Gougeon, who co-founded the company with Kurt Amplatz in 1995. AGA says that Gougeon has decided to transition from day-to-day company oversight to an expanded role in long-term strategic planning. He will remain a member of the company's board and will chair a new corporate development committee